August 16, 2019
By
Jo Ravelingien
1
min read

RemeCare "M1 approved" by mHealthBelgium

RemeCare Oncology was one of the first four mHealth apps included in the validation pyramid of mHealthBelgium. This approval means that this health application RemeCare Oncology has taken a first step towards a potential reimbursement when using this mobile application to guide cancer patients with their medication intake and monitor possible side effects during their chemotherapy.

This first step means that the government acknowledges that Remedus does have a CE certificate for the software as a medical device and that Remedus complies with the applicable GDPR legislation. The decision on a final reimbursement will follow in a further phase as you can read here.

Stay updated about new content and the latest RemeCare news.

Thank you! An email is on its way. Curious for more? Schedule a demo here.

Didn't receive anything from us within a few minutes? 

A few things could have happened:

  • The email is in your spam folder. (Sometimes things get lost in there. Make sure to mark it as "safe"!)
  • The email address you entered had a mistake or typo. (Happens to the best of us.)
  • You accidentally gave us another email address. (Usually a work or personal one instead of the one you meant.)
  • We can’t deliver the email to this address. (Usually because of corporate firewalls or filtering.)
Oops! Something went wrong while submitting the form. Make sure to enter a valid email address.